Methodist Children's Hospital in San Antonio, Texas; Nationwide ... Vertex is a global biotechnology company that invests in scientific innovation ...
News
- Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY ... - BioSpace
- Genentech's Inavolisib Combination Reduces the Risk of Disease Progression by 57% in ...
... San Antonio Breast Cancer Symposium and shared with health authorities – ... Founded more than 40 years ago, Genentech is a leading biotechnology ...
- Ribometrix Demonstrates Rapid Progress for eIF4E Program at San Antonio Breast Cancer ...
... San Antonio Breast Cancer Symposium (SABCS), held December 5-9, 2023, in San Antonio, TX ... biotechnology company developing small molecule ...
- Patients With HR-Positive Breast Cancer Can Safely Use ART - Medscape
SAN ANTONIO — Fertility preservation and/or assisted reproductive technologies do not increase the risk for short-term cancer recurrence in young ...
- T-DM1 Falls Short in Elderly Patients With Advanced, HER2+ Breast Cancer
... San Antonio Breast Cancer Symposium 2023. T-DMI failed to show non ... Disclosures: Dr Shimomura declared affiliations with biotech, pharmaceutical, and ...